Multiple Sclerosis Clinical Trial
Official title:
Investigation of the Effects of Selective Exercise Training on Muscle Architecture, Balance, Function and Fatigue in Multiple Sclerosis
Verified date | December 2021 |
Source | Sanko University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Selective exercise programs specific to muscle groups, with the workload to be done in line with the muscle's own structure, can enable more strength to be released with less fatigue in MS, and this increase in strength can increase balance and functional activities. to determine the effects of type training (selective exercise training), eccentric and concentric training on function, balance, fatigue and muscle architecture.
Status | Completed |
Enrollment | 33 |
Est. completion date | June 15, 2020 |
Est. primary completion date | April 15, 2020 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 50 Years |
Eligibility | Inclusion Criteria: - Between the ages of 18-50, - With an Extended Disability Status Scale (EDSS) score of 4 or less, - No regular exercise habit - Able to walk on the treadmill, - No pregnancy, - Not receiving corticosteroid treatment in the last month, - Fampridine etc. in the last 1 month. not taking medication, - Patients who have not received Botox treatment in the last 6 months Exclusion Criteria: patients who do not agree to volunteer |
Country | Name | City | State |
---|---|---|---|
Turkey | Zekiye Ipek Katirci Kirmaci | Gaziantep |
Lead Sponsor | Collaborator |
---|---|
Sanko University |
Turkey,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | muscle architecture parameter 1 | The pennation angle were evaluated with Ultrasound | Change from Baseline at 8th weeks and 12th weeks | |
Primary | muscle architecture parameter 2 | The fiber length were evaluated with Ultrasound | Change from Baseline at 8th weeks and 12th weeks | |
Primary | muscle architecture parameter 3 | The muscle thickness were evaluated with Ultrasound | Change from Baseline at 8th weeks and 12th weeks | |
Primary | Muscle strength | low extremity muscles were evaluated with hand dynamometer | Change from Baseline at 8th weeks and 12th weeks | |
Secondary | walking fatigue | Walking Fatigue Index | Change from Baseline at 8th weeks and 12th weeks | |
Secondary | perceived fatigue | Fatigue Severity Scale | Change from Baseline at 8th weeks and 12th weeks | |
Secondary | physical fatigue | Modified Borg Scale before and after 6-minute walking test | Change from Baseline at 8th weeks and 12th weeks | |
Secondary | static balance | Single standing tests | Change from Baseline at 8th weeks and 12th weeks | |
Secondary | dynamic balance | 4 square step tests | Change from Baseline at 8th weeks and 12th weeks | |
Secondary | Functional activities 1 | timed-up go test | Change from Baseline at 8th weeks and 12th weeks | |
Secondary | Functional activities 2 | 2-minute walk test | Change from Baseline at 8th weeks and 12th weeks | |
Secondary | Functional activities 3 | 25-feet walk test | Change from Baseline at 8th weeks and 12th weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05528666 -
Risk Perception in Multiple Sclerosis
|
||
Completed |
NCT03608527 -
Adaptive Plasticity Following Rehabilitation in Multiple Sclerosis
|
N/A | |
Recruiting |
NCT05532943 -
Evaluate the Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells in Patients With Multiple Sclerosis
|
Phase 1/Phase 2 | |
Completed |
NCT02486640 -
Evaluation of Potential Predictors of Adherence by Investigating a Representative Cohort of Multiple Sclerosis (MS) Patients in Germany Treated With Betaferon
|
||
Completed |
NCT01324232 -
Safety and Efficacy of AVP-923 in the Treatment of Central Neuropathic Pain in Multiple Sclerosis
|
Phase 2 | |
Completed |
NCT04546698 -
5-HT7 Receptor Implication in Inflammatory Mechanisms in Multiple Sclerosis
|
||
Active, not recruiting |
NCT04380220 -
Coagulation/Complement Activation and Cerebral Hypoperfusion in Relapsing-remitting Multiple Sclerosis
|
||
Completed |
NCT02835677 -
Integrating Caregiver Support Into MS Care
|
N/A | |
Completed |
NCT03686826 -
Feasibility and Reliability of Multimodal Evoked Potentials
|
||
Recruiting |
NCT05964829 -
Impact of the Cionic Neural Sleeve on Mobility in Multiple Sclerosis
|
N/A | |
Withdrawn |
NCT06021561 -
Orofacial Pain in Multiple Sclerosis
|
||
Completed |
NCT03653585 -
Cortical Lesions in Patients With Multiple Sclerosis
|
||
Recruiting |
NCT04798651 -
Pathogenicity of B and CD4 T Cell Subsets in Multiple Sclerosis
|
N/A | |
Active, not recruiting |
NCT05054140 -
Study to Evaluate Efficacy, Safety, and Tolerability of IMU-838 in Patients With Progressive Multiple Sclerosis
|
Phase 2 | |
Completed |
NCT05447143 -
Effect of Home Exercise Program on Various Parameters in Patients With Multiple Sclerosis
|
N/A | |
Recruiting |
NCT06195644 -
Effect of Galvanic Vestibular Stimulation on Cortical Excitability and Hand Dexterity in Multiple Sclerosis Patients
|
Phase 1 | |
Completed |
NCT04147052 -
iSLEEPms: An Internet-Delivered Intervention for Sleep Disturbance in Multiple Sclerosis
|
N/A | |
Completed |
NCT03594357 -
Cognitive Functions in Patients With Multiple Sclerosis
|
||
Completed |
NCT03591809 -
Combined Exercise Training in Patients With Multiple Sclerosis
|
N/A | |
Completed |
NCT03269175 -
BENEFIT 15 Long-term Follow-up Study of the BENEFIT and BENEFIT Follow-up Studies
|
Phase 4 |